On the one hand, some studies have described a positive correlation between nontaster status and severe COVID-19-related symptomatology [25]; on the other, the only available study in the literature that genetically investigated the TAS2R38 haplotype in COVID-19 patients reported no correlation between TA2R38 activity and symptom severity [26]. The gene discussed is TAS2R38; the disease is COVID-19.